Previous Article | Next Article ![]()
J. Virol., 10 1997, 7167-7179, Vol 71, No. 10
ER Flores and PF Lambert
The study of human papillomavirus type 16 (HPV-16) replication has been
impaired because of the lack of a cell culture system that stably maintains
viral replication. Recently, cervical epithelial cell populations that
stably maintain HPV-16 replicons at a copy number of approximately 1,000
per cell were derived from an HPV-16-infected patient (W12 cell clone 20863
[W12-E cells]). We used neutral/neutral and neutral/alkaline
two-dimensional gel electrophoretic techniques to characterize HPV-16 DNA
replication in these cells. When W12-E cells were maintained in an
undifferentiated state mimicking the nonproductive stage of the life cycle,
HPV-16 DNA was found to replicate primarily by theta structures in a
bidirectional manner. The initiation site of HPV-16 DNA replication was
mapped to approximately nucleotide 100, and the termination site was mapped
to between nucleotides 3398 and 5990. To study the productive stage of
HPV-16 DNA replication, W12-E cells were grown under culture conditions
that promote differentiation of epithelial cell types. Under these
conditions, where virus-like particles were detected, the mode of viral DNA
replication changed from theta structure to what is apparently a rolling
circle mode. Additionally, CIN 612-9E cells, which were derived from an
HPV-31-infected patient and harbor HPV-31 extrachromosomally, exhibited the
same switch in the mode of DNA replication upon induction of
differentiation. These data argue that a fundamental switch in the
mechanism of viral DNA replication occurs during the life cycle of the
papillomavirus.
Copyright © 1997, American Society for Microbiology
Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle
McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison 53706, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|